365 related articles for article (PubMed ID: 20157253)
1. Ginsenoside Rg1 attenuates amyloid-beta content, regulates PKA/CREB activity, and improves cognitive performance in SAMP8 mice.
Shi YQ; Huang TW; Chen LM; Pan XD; Zhang J; Zhu YG; Chen XC
J Alzheimers Dis; 2010; 19(3):977-89. PubMed ID: 20157253
[TBL] [Abstract][Full Text] [Related]
2. Multi-faced neuroprotective effects of Ginsenoside Rg1 in an Alzheimer mouse model.
Fang F; Chen X; Huang T; Lue LF; Luddy JS; Yan SS
Biochim Biophys Acta; 2012 Feb; 1822(2):286-92. PubMed ID: 22015470
[TBL] [Abstract][Full Text] [Related]
3. Long-term green tea catechin administration prevents spatial learning and memory impairment in senescence-accelerated mouse prone-8 mice by decreasing Abeta1-42 oligomers and upregulating synaptic plasticity-related proteins in the hippocampus.
Li Q; Zhao HF; Zhang ZF; Liu ZG; Pei XR; Wang JB; Li Y
Neuroscience; 2009 Oct; 163(3):741-9. PubMed ID: 19596052
[TBL] [Abstract][Full Text] [Related]
4. Long-term ginsenoside consumption prevents memory loss in aged SAMP8 mice by decreasing oxidative stress and up-regulating the plasticity-related proteins in hippocampus.
Zhao H; Li Q; Zhang Z; Pei X; Wang J; Li Y
Brain Res; 2009 Feb; 1256():111-22. PubMed ID: 19133247
[TBL] [Abstract][Full Text] [Related]
5. Ginsenoside Rg1 attenuates β-amyloid generation via suppressing PPARγ-regulated BACE1 activity in N2a-APP695 cells.
Chen LM; Lin ZY; Zhu YG; Lin N; Zhang J; Pan XD; Chen XC
Eur J Pharmacol; 2012 Jan; 675(1-3):15-21. PubMed ID: 22166376
[TBL] [Abstract][Full Text] [Related]
6. Ginsenoside Rg1 ameliorates hippocampal long-term potentiation and memory in an Alzheimer's disease model.
Li F; Wu X; Li J; Niu Q
Mol Med Rep; 2016 Jun; 13(6):4904-10. PubMed ID: 27082952
[TBL] [Abstract][Full Text] [Related]
7. The effects of ginsenoside Rg1 on chronic stress induced depression-like behaviors, BDNF expression and the phosphorylation of PKA and CREB in rats.
Liu Z; Qi Y; Cheng Z; Zhu X; Fan C; Yu SY
Neuroscience; 2016 May; 322():358-69. PubMed ID: 26926964
[TBL] [Abstract][Full Text] [Related]
8. Ginsenoside Rg1 decreases Aβ(1-42) level by upregulating PPARγ and IDE expression in the hippocampus of a rat model of Alzheimer's disease.
Quan Q; Wang J; Li X; Wang Y
PLoS One; 2013; 8(3):e59155. PubMed ID: 23520555
[TBL] [Abstract][Full Text] [Related]
9. Ginsenoside Rg1 promotes nonamyloidgenic cleavage of APP via estrogen receptor signaling to MAPK/ERK and PI3K/Akt.
Shi C; Zheng DD; Fang L; Wu F; Kwong WH; Xu J
Biochim Biophys Acta; 2012 Apr; 1820(4):453-60. PubMed ID: 22178929
[TBL] [Abstract][Full Text] [Related]
10. Long-term ginsenoside administration prevents memory impairment in aged C57BL/6J mice by up-regulating the synaptic plasticity-related proteins in hippocampus.
Zhao H; Li Q; Pei X; Zhang Z; Yang R; Wang J; Li Y
Behav Brain Res; 2009 Aug; 201(2):311-7. PubMed ID: 19428650
[TBL] [Abstract][Full Text] [Related]
11. Ginsenoside Rg1 reverses stress-induced depression-like behaviours and brain-derived neurotrophic factor expression within the prefrontal cortex.
Zhu X; Gao R; Liu Z; Cheng Z; Qi Y; Fan C; Yu SY
Eur J Neurosci; 2016 Jul; 44(2):1878-85. PubMed ID: 27062560
[TBL] [Abstract][Full Text] [Related]
12. Long-term ginsenoside Rg1 supplementation improves age-related cognitive decline by promoting synaptic plasticity associated protein expression in C57BL/6J mice.
Yang L; Zhang J; Zheng K; Shen H; Chen X
J Gerontol A Biol Sci Med Sci; 2014 Mar; 69(3):282-94. PubMed ID: 23833204
[TBL] [Abstract][Full Text] [Related]
13. Minor ginsenoside F1 improves memory in APP/PS1 mice.
Han J; Oh JP; Yoo M; Cui CH; Jeon BM; Kim SC; Han JH
Mol Brain; 2019 Sep; 12(1):77. PubMed ID: 31488185
[TBL] [Abstract][Full Text] [Related]
14. Improvement of spatial memory function in APPswe/PS1dE9 mice after chronic inhibition of phosphodiesterase type 4D.
Sierksma AS; van den Hove DL; Pfau F; Philippens M; Bruno O; Fedele E; Ricciarelli R; Steinbusch HW; Vanmierlo T; Prickaerts J
Neuropharmacology; 2014 Feb; 77():120-30. PubMed ID: 24067928
[TBL] [Abstract][Full Text] [Related]
15. Tripchlorolide improves age-associated cognitive deficits by reversing hippocampal synaptic plasticity impairment and NMDA receptor dysfunction in SAMP8 mice.
Lin N; Pan XD; Chen AQ; Zhu YG; Wu M; Zhang J; Chen XC
Behav Brain Res; 2014 Jan; 258():8-18. PubMed ID: 24140565
[TBL] [Abstract][Full Text] [Related]
16. Chronic treatment with ginsenoside Rg1 promotes memory and hippocampal long-term potentiation in middle-aged mice.
Zhu G; Wang Y; Li J; Wang J
Neuroscience; 2015 Apr; 292():81-9. PubMed ID: 25724866
[TBL] [Abstract][Full Text] [Related]
17. Effects of ginsenoside Rg1 or 17β-estradiol on a cognitively impaired, ovariectomized rat model of Alzheimer's disease.
Zhang X; Wang J; Xing Y; Gong L; Li H; Wu Z; Li Y; Wang J; Wang Y; Dong L; Li S
Neuroscience; 2012 Sep; 220():191-200. PubMed ID: 22728092
[TBL] [Abstract][Full Text] [Related]
18. Tripchlorolide improves cognitive deficits by reducing amyloid β and upregulating synapse-related proteins in a transgenic model of Alzheimer's Disease.
Zeng Y; Zhang J; Zhu Y; Zhang J; Shen H; Lu J; Pan X; Lin N; Dai X; Zhou M; Chen X
J Neurochem; 2015 Apr; 133(1):38-52. PubMed ID: 25661995
[TBL] [Abstract][Full Text] [Related]
19. Beneficial effects of asiaticoside on cognitive deficits in senescence-accelerated mice.
Lin X; Huang R; Zhang S; Wei L; Zhuo L; Wu X; Tang A; Huang Q
Fitoterapia; 2013 Jun; 87():69-77. PubMed ID: 23562630
[TBL] [Abstract][Full Text] [Related]
20. Effects of accelerated senescence on learning and memory, locomotion and anxiety-like behavior in APP/PS1 mouse model of Alzheimer's disease.
Lok K; Zhao H; Zhang C; He N; Shen H; Wang Z; Zhao W; Yin M
J Neurol Sci; 2013 Dec; 335(1-2):145-54. PubMed ID: 24095271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
